Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...

The FDA approved the first generic dapagliflozin tablets, opening a competitive US market for pharma manufacturers and ...

From a more affordable diabetes drug to a surprising cancer connection at home, here's what's making health headlines today.

Multiple manufacturers receive FDA approval for generic dapagliflozin to treat type 2 diabetes and lower heart failure risks in high-risk T2D patients.

Officials with the FDA have approved the first generic omeprazole oral paste for the treatment of gastric ulcers and ...

India's obesity treatment market is set to expand rapidly as local drugmakers prepare to release affordable versions of Novo ...

Indian drugmakers begin selling generic Ozempic copies at $14 monthly Friday — 88% cheaper than Novo's brand-name version.

The expiration of Novo Nordisk’s semaglutide patent on March 20, 2026, has triggered a massive shift in India’s ₹1,600 crore ...

The Go team has approved generic methods, reversing a longstanding position in the language's FAQ. The proposal, from Go co-designer Robert Griesemer, now moves to implementation.… A key issue – that ...

Generative artificial intelligence (GenAI) is opening the door for more researchers to conduct consumer studies than ever ...